ctrl K

Price Alert

PDS Biotechnology Corpora... (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.20

0.00 (0.00%)

At close: Aug 15, 2025, 3:59 PM

1.22

1.66%

After-hours: Aug 15, 2025, 07:12 PM EDT

PDS Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	41.69M	56.56M	73.82M	65.24M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	3.36M	n/a	2.66M	n/a
Total Current Assets	45.05M	59.06M	76.48M	66.84M
Property-Plant & Equipment	304.21K	335K	527.53K	357.7K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	304.21K	335K	527.53K	357.7K
Total Assets	45.36M	59.39M	77.01M	67.2M
Account Payables	1.68M	6.98M	1.22M	1.31M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	12.5M	4.17M	288.04K	258.92K
Other Current Liabilities	663.4K	1.14M	-288.04K	470.47K
Total Current Liabilities	17.09M	13.63M	9.82M	3.76M
Long-Term Debt	9.2M	19.51M	23.02M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	9.27M	19.63M	23.18M	231.43K
Total Liabilities	26.35M	33.26M	33.01M	3.99M
Total Debt	21.83M	23.85M	23.47M	490.35K
Common Stock	12.54K	10.92K	9.96K	9.39K
Retained Earnings	-182.11M	-144.5M	-101.56M	-60.7M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	19M	26.13M	44M	63.21M
Total Investments	n/a	n/a	n/a	n/a